Postler Thomas Siegmund, Ghosh Sankar
Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Cell Metab. 2017 Jul 5;26(1):110-130. doi: 10.1016/j.cmet.2017.05.008. Epub 2017 Jun 15.
The human gastrointestinal tract is populated by a diverse, highly mutualistic microbial flora, which is known as the microbiome. Disruptions to the microbiome have been shown to be associated with severe pathologies of the host, including metabolic disease, cancer, and inflammatory bowel disease. Mood and behavior are also susceptible to alterations in the gut microbiota. A particularly striking example of the symbiotic effects of the microbiome is the immune system, whose cells depend critically on a diverse array of microbial metabolites for normal development and behavior. This includes metabolites that are produced by bacteria from dietary components, metabolites that are produced by the host and biochemically modified by gut bacteria, and metabolites that are synthesized de novo by gut microbes. In this review, we highlight the role of the intestinal microbiome in human metabolic and inflammatory diseases and focus in particular on the molecular mechanisms that govern the gut-immune axis.
人类胃肠道中栖息着种类多样、高度互利共生的微生物群落,即微生物组。研究表明,微生物组的破坏与宿主的严重病理状况有关,包括代谢性疾病、癌症和炎症性肠病。情绪和行为也容易受到肠道微生物群变化的影响。微生物组共生效应的一个特别显著的例子是免疫系统,其细胞的正常发育和功能严重依赖于多种微生物代谢产物。这些代谢产物包括由细菌利用饮食成分产生的代谢产物、由宿主产生并经肠道细菌进行生化修饰的代谢产物,以及由肠道微生物从头合成的代谢产物。在本综述中,我们强调肠道微生物组在人类代谢和炎症性疾病中的作用,并特别关注调控肠道-免疫轴的分子机制。